| 1 | TSRI: CoV-2/HeLa-ACE2 | SARS-COV2 | screened, not a selected hit | Calibr |
|---|
| 2 | TB oxidative phosphorylation inhibitor | M. TUBERCULOSIS | screened, not a selected hit | Calibr |
|---|
| 3 | TB IMAC Assay | TUBERCULOSIS | screened, not a selected hit | Calibr |
|---|
| 4 | Crypto-C. parvum proliferation (Sterling) | CRYPTOSPORIDIOSIS | screened, not a selected hit | Calibr |
|---|
| 5 | TB growth inhibition | M. TUBERCULOSIS | screened, not a selected hit | Calibr |
|---|
| 6 | Intracellular nonreplicating MTB screen | TUBERCULOSIS | screened, not a selected hit | Calibr |
|---|
| 7 | STING agonist | IMMUNOONCOLOGY; ADJUVANTS | screened, not a selected hit | Calibr |
|---|
| 8 | Wolbachia high-content imaging | HELMINTH: ANTI-WOLBACHIA | screened, not a selected hit | Calibr |
|---|
| 9 | Malaria Sporontocidals | MALARIA | screened, not a selected hit | Calibr |
|---|
| 10 | Zika cytopathic effect inhibition (SH-SY5Y) | ZIKA | screened, not a selected hit | Calibr |
|---|
| 11 | Zika Cytopathic Effect Inhibition in Vero E6 cells | ZIKA | screened, not a selected hit | Calibr |
|---|
| 12 | TB Tyr-tRNA synthetase inhibitor | M. TUBERCULOSIS | screened, not a selected hit | Calibr |
|---|
| 13 | A. baumannii HUMC1 Viability serum | EXTENSIVELY DRUG-RESISTANT ACINETOBACTER BAUMANNII | screened, not a selected hit | Calibr |
|---|
| 14 | Intramacrophage Mycobacterium tuberculosis | TUBERCULOSIS | screened, not a selected hit | Calibr |
|---|
| 15 | TB DGr | TUBERCULOSIS | screened, not a selected hit | Calibr |
|---|
| 16 | MAVS Aggregation Assay | IMMUNOONCOLOGY; ADJUVANTS | screened, not a selected hit | Calibr |
|---|
| 17 | A. baumannii HUMC1 Meropenem Potentiation serum | EXTENSIVELY DRUG-RESISTANT ACINETOBACTER BAUMANNII | screened, not a selected hit | Calibr |
|---|
| 18 | Burkholderia pseudomallei K96243 | MELIOIDOSIS | screened, not a selected hit | Calibr |
|---|
| 19 | Screen in Luciferase-expressing E. histolytica | AMEBIASIS | screened, not a selected hit | Calibr |
|---|
| 20 | Viability on Pathogenic Acanthamoeba Castellanii | GRANULOMATOUS AMEBIC ENCEPHALITIS (GAE) | screened, not a selected hit | Calibr |
|---|
| 21 | Cell Viability on Pathogenic Naegleria fowleri | PRIMARY AMOEBIC MENINGOENCEPHALITIS (PAM) | screened, not a selected hit | Calibr |
|---|
| 22 | Shigella flexneri growth inhibition | SHIGELLOSIS | screened, not a selected hit | Calibr |
|---|
| 23 | SigmaE-Hfq inhibition | BACTERIAL INFECTIONS | screened, not a selected hit | Calibr |
|---|
| 24 | Giardia 1536w Luciferase Assay | GIARDIASIS | screened, not a selected hit | Calibr |
|---|
| 25 | LCMV Inhibitors | MAMMARENAVIRUS LYMPHOCYTIC CHORIOMENINGITIS VIRUS (LCMV) | screened, not a selected hit | Calibr |
|---|
| 26 | tmRNA | BACTERIAL INFECTIONS | screened, not a selected hit | Calibr |
|---|
| 27 | Trypanosoma cruzi Assay | CHAGAS | screened, not a selected hit | Calibr |
|---|
| 28 | THP1-ISRE-SEAP | IMMUNOONCOLOGY; ADJUVANTS | screened, not a selected hit | Calibr |
|---|
| 29 | Male Contraceptive Screen (Motility) | HUMAN CONTRACEPTION | screened, not a selected hit | Calibr |
|---|
| 30 | Inhibitor of microbial choline metabolism | GROWTH OF E. COLI ON CHOLINE-CONTAINING MINIMAL MEDIA | screened, not a selected hit | Calibr |
|---|
| 31 | WRAIR LADR-luc Assay (4 day) | CUTANEOUS LEISHMANIASIS | screened, not a selected hit | Calibr |
|---|
| 32 | Biofilm-Inhibitory of Candida Growth | CANDIDIASIS | screened, not a selected hit | Calibr |
|---|
| 33 | ppGpp hydrolysis assay | TUBERCULOSIS | screened, not a selected hit | Calibr |
|---|
| 34 | Block Rings and Gametocytes to Eradicate Malaria | PLASMODIUM FALCIPARUM | screened, not a selected hit | Calibr |
|---|
| 35 | Mtb TrpRS Biochemical Screening | TUBERCULOSIS | screened, not a selected hit | Calibr |
|---|
| 36 | Screen against Klebsiella pneumoniae (Kp) 757 | KLEBSIELLA PNEUMONIAE INFECTIONS | screened, not a selected hit | Calibr |
|---|
| 37 | hRSV High Throughput Screen | HUMAN RESPIRATORY SYNCYTIAL VIRUS (HRSV) | screened, not a selected hit | Calibr |
|---|
| 38 | DENV transmission blocking molecules (U4.4 cells) | DENGUE VIRUS INFECTION (DENGUE FEVER AND HEMORRHAGIC FEVER) | screened, not a selected hit | Calibr |
|---|
(20min delay)